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Abstract Surface PEGylation of polystyrene microspheres
with methoxy-poly(ethylene glycol)-5000 (mPEG-5000) gener-
ated a heterogeneous population of entities that di¡ered in sur-
face characteristics and in vitro biological performance (phago-
cytosis and complement activation). Surface heterogeneity was
determined by hydrophobic interaction chromatography, mea-
surements of particle electrophoretic mobility in a de¢ned ¢eld
and adlayer thickness of the projected mPEG chains. The par-
ticle population separation by hydrophobic interaction chroma-
tography demonstrated a remarkable linear relationship between
the particle zeta potential and phagocytosis by J774 A1 macro-
phage-like cells. Microsphere populations bearing a predomi-
nant surface of mPEG molecules as high-density mushroom^
brush intermediate and/or brush con¢guration were most resis-
tant to phagocytosis and activated the human complement sys-
tem poorly. Conversely, those populations with predominant sur-
face mPEGs in a mushroom regime were potent activators of
the complement system and were prone to phagocytosis. There-
fore, surface heterogeneity explains why a fraction of intrave-
nously injected ‘long-circulating’ nanoparticles is cleared rapidly
by macrophages of the reticuloendothelial system. Hydrophobic
interaction chromatography can readily assess the extent of sur-
face heterogeneity of PEGylated particulate drug delivery sys-
tems and pre-select particles with optimal retention times in the
blood. These observations may also be relevant with respect to
successful surface camou£aging of cells, drug depots and im-
plantable devices.
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lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Recently, we described a simple two-step approach for sur-
face enrichment of polystyrene particles with methoxy-poly-
(ethylene glycol)-5000 (mPEG-5000) in order to generate en-
tities which are resistant to macrophage recognition and hence
exhibit prolonged circulation times in the blood [1]. Here, the
surface of polystyrene particles was ¢rst enriched with bovine
serum albumin (BSA) at the top plateau region of the adsorp-
tion isotherm, where BSA molecules form a close-packed
monolayer. The nucleophiles of the adsorbed BSA monolayer
were then conjugated with molar excess quantities of cyanuric
chloride-activated mPEG-5000. However, within the ¢rst hour
of intravenous injection into rats, a signi¢cant fraction of
these PEGylated particles, corresponding to 25% of the initial
dose, was captured by the liver macrophages [1]. This phe-
nomenon is also similar to biodistribution of other studied
surface-camou£aged particles such as PEG-grafted liposomes
and nanoparticles coated with PEG-R-type copolymers where
R is poly(lactic acid) or poly(lactide-co-glycolide) (reviewed in
[2]). Biophysical characterisation of PEGylated particles dem-
onstrated that the preparation was composed of two di¡erent
populations of entities of similar size distribution but with
di¡erent surface hydrophilicity [1]. The minor population,
corresponding to approximately 20% of the total, was prone
to phagocytosis and hence did not exhibit prolonged circula-
tion times in the blood. Di¡erences in hydrophilicity indicate
variant surface coverage of modi¢ed particles by mPEG mol-
ecules. Therefore, variable surface heterogeneity explains why
a signi¢cant fraction of intravenously injected mPEG-grafted
particles is rapidly sequestered by macrophages in contact
with blood.
From a cancer therapeutic point of view, macrophage se-
questration of PEGylated particles may be problematic. For
example, following uptake and subsequent intracellular re-
lease of the encapsulated anti-cancer drug macrophage apo-
ptosis is induced, a process which leads to depletion of a
signi¢cant number of the host’s defence cells [3,4]. In the
case of the liver, restoration of Kup¡er cells may take up to
2 weeks; this period of Kup¡er cell de¢ciency may be asso-
ciated with conditions such as bacteraemia, which is poten-
tially fatal in some patients [4]. Therefore, it is necessary to
re¢ne surface engineering strategies that yield a single popu-
lation of particles with a homogeneous macrophage-repelling
surface.
This article examines physicochemical parameters which de-
termine surface heterogeneity of well-de¢ned model BSA-
coated polystyrene particles following PEGylation with acti-
vated mPEG-5000. Therefore, we have studied how the mode
of BSA adsorption (a close-packed monolayer versus a disor-
ganised surface structure) on to polystyrene particles can af-
fect surface PEGylation in terms of the number of attached
mPEG molecules per adsorbed BSA molecule, mPEG con¢g-
uration (brush versus mushroom or £at regimes), and particle
population heterogeneity. These approaches have led us to
successfully establish a correlation between surface parameters
and the biological performance (complement activation and
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phagocytosis) of the engineered particles. We also provide
essential guidelines for the design of nanospheres with optimal
macrophage-resistant properties.
2. Materials and methods
2.1. Surface engineering of polystyrene particles (protein adsorption
and PEGylation)
Polystyrene particles (2.5% w/v), 1.0 Wm in diameter, manufactured
by Polysciences (Warrington, PA, USA), were purchased from Park
Scienti¢c (Northampton, UK). In some experiments polystyrene par-
ticles were surface labelled with Na[125I] (Amersham Pharmacia Bio-
tech, Amersham, UK) as described previously [1]. The surface of the
polystyrene particles was modi¢ed with BSA. Initially, an adsorption
isotherm of BSA on polystyrene lattices was constructed as described
in detail elsewhere [1,5]. Brie£y, protein solutions were prepared in
phosphate bu¡er, pH 7.4 and ionic strength of 0.15. Protein-coated
particles were prepared by adding 2.5 mg of polystyrene particles,
corresponding to 4.25U109 particles, with a total surface area of
0.014 m2, to protein solutions ranging from 0 to 650 Wg/ml BSA in
a total volume of 1.0 ml in triplicate Eppendorf tubes. All tubes were
shaken gently (100 rpm) for 24 h at 24‡C in a water bath. The sus-
pensions were then centrifuged for 30 min at 16 000Ug. For each
protein concentration a control tube was prepared without any poly-
styrene particles to account for any protein loss due to adsorption to
the Eppendorf tubes. Protein concentrations were determined by Bio-
Rad assay for the resulting supernatants using a standard curve run
concurrently with the adsorption experiment. In a series of further
experiments, polystyrene particles incubated in 250 and 600 Wg
BSA/ml were centrifuged for 30 min at 16 000Ug ; after four washing
steps and subsequent centrifugation no more protein was detected in
the supernatant as assessed by the Bio-Rad protein assay solution. No
polystyrene particles were lost in supernatants as monitored by light
scattering during the centrifugation steps. The cleaned particles were
¢nally resuspended in either phosphate bu¡er or 0.1 M sodium tetra-
borate at pH 9.2, and gently shaken for 24 h at 24‡C to determine
whether any protein could desorb. These experiments demonstrated
strong association of the adsorbed proteins with polystyrene particles
as no protein was detected in the supernatant. Finally, protein-coated
particles were suspended in 0.1 M sodium tetraborate at pH 9.2.
Cyanuric chloride-activated mPEG-5000 was added to the suspen-
sions in excess (in 50-fold molar excess to the adsorbed albumin)
and incubated for 1 h at 4‡C; the total volume was kept to 1.0 ml.
The chemical basis of this reaction is discussed elsewhere [1]. Unat-
tached PEG molecules were removed by centrifugation at 16 000Ug
for 30 min. Finally, particles were suspended in 10 mM phosphate
bu¡er, pH 7.2, and washed three times to ensure the complete remov-
al of unconjugated PEGs. Removal of free PEG and the quantity of
adsorbed conjugated mPEG^BSA were determined by the colorimet-
ric assay of Nag et al. [6].
2.2. Particle size and electrophoretic mobility
The hydrodynamic radius and the electrophoretic mobility of par-
ticles were determined by photon correlation spectroscopy (PCS) and
laser Doppler electrophoresis, respectively, in 10 mM McIlvaine bu¡-
er, pH 7.2, at 24‡C using a Zetasizer 3000 system (Malvern Instru-
ments, UK) as described previously [1]. PCS measurements (based on
CONTIN analysis) were determined at a wavelength of 633 nm, scat-
tering angle of 90‡, dispersant viscosity of 0.89 cP and refractive index
of 1.35. For electrophoretic mobility measurements the conditions
were as follows: dielectric constant 78.3, current 1.4 mA, £uid refrac-
tive index of 1.35, cell ¢eld of 29.3 V/cm, viscosity of 0.89 cP and
conductivity of 0.7 mS/cm.
2.3. Hydrophobic interaction chromatography
The interaction of PEGylated particles in the hydrophobic column
was investigated by adsorption to and elution from pentyl-agarose [1].
For this, pre-packed columns containing 2.5 ml pentyl-agarose (Sig-
ma-Aldrich Company, Poole, UK) were used. In all experiments par-
ticles (0.5 mg) were suspended in 10 mM phosphate bu¡er (pH 7.2)
with 1.0 M sodium chloride to promote interaction. The column was
equilibrated with the same bu¡er. Elution was made by decreasing the
concentration of sodium chloride and concurrently increasing the con-
centration of Triton X-100 (from 0.0 to 0.1% v/v). No aggregation of
the sample was observed before application onto the column. The
elution pattern was read using a spectrophotometer (V=450 nm) or
by radioactivity (when particles were surface labelled with 125I).
Pooled fractions were concentrated by centrifugation for 60 min at
16 000Ug and washed twice with 10 mM phosphate bu¡er prior to
further analysis. In some experiments pooled fractions were concen-
trated by centrifugation and after cleaning incubated in 0.1% w/v
solution of poloxamine 908 (BASF, Mt. Olive, NJ, USA) for 1 h at
room temperature. Following incubation, the suspension was centri-
fuged and washed twice to remove free poloxamine 908 molecules.
2.4. Residual total complement haemolytic assay
Freshly obtained human serum was diluted with an equal volume of
isotonic veronal-bu¡ered saline (containing 0.5 mM MgCl2, 0.15 mM
CaCl2 and 0.1% w/v gelatin). Diluted human serum samples (50 Wl)
were incubated with an equal volume of particle suspensions (0.2 mg
polystyrene) at 37‡C for 1 h. After the incubation period, the mixtures
were diluted with 150 Wl of isotonic veronal-bu¡ered saline and kept
on ice. Residual total complement haemolytic activity of particle-
treated serum was measured according to established methods [7].
Brie£y, sheep erythrocytes were sensitised with rabbit anti-sheep
erythrocyte antibody and suspended to 1.5U108 cells/ml in isotonic
veronal-bu¡ered saline. In triplicate, 50 Wl antibody-sensitised cells
were incubated with 50 Wl of particle-treated serum for 30 min at
37‡C. Samples were then diluted by the addition of 2 ml of dex-
trose^gelatin veronal-bu¡ered saline containing 40 mM EDTA. Un-
lysed erythrocytes were pelleted by centrifugation and the amount of
haemoglobin released into the supernatant was quanti¢ed spectropho-
tometrically at 414 nm. Blanks and 100% lysis controls were also
performed. The residual complement haemolytic activity was also as-
sessed in heat-treated serum (56‡C, 30 min) as well as zymosan-treated
serum. The residual complement haemolytic activity of the treated
serum is expressed as a percentage of the total haemolytic level as
determined in the 100% lysis control. The above experiments were
repeated three times and each time serum was obtained from a di¡er-
ent healthy individual.
2.5. Phagocytic assay
Phagocytosis was monitored using 125I-labelled polystyrene par-
ticles. The J774 A1 murine macrophage-like cell line was plated in
48-well tissue culture dishes at a density of 5U105 cells per well in
RPMI medium containing 10% v/v foetal bovine serum. In order to
remove non-adherent cells, cells were washed 1 h after plating with
fresh RPMI medium. Cell viability, as determined by dye exclusion,
was greater than 95% after 24 h of incubation at 37‡C. After 24 h
incubation at 37‡C, polystyrene particles of di¡erent surface charac-
teristics (5U108 particles per well) were added and the cells were left
to incubate for an additional 6 h. All incubations with polystyrene
particles contained 10% v/v foetal bovine serum, thus to account for
possible opsonisation events. At the end of the incubation, cells were
washed three times with RPMI medium, then solubilised with KOH,
and total radioactivity associated with cell lysate was determined us-
ing a gamma counter. For each polystyrene particle type triplicate
incubations were performed.
3. Results
3.1. Surface engineering and particle characterisation
In agreement with previous studies [1,5] the results in Fig. 1
demonstrate that at a pH of 7.4 and ionic strength of 0.15,
BSA has a high a⁄nity for the polystyrene particle surface at
low concentrations. The isotherm is trimodal. After an initial
sharp increase, the isotherm breaks at approximately 0.6 mg/
m2, then begins to rise again and levels out around 1.1 mg/m2
and ¢nally reaches a plateau limit of approximately 2.0 mg/
m2. All features of this isotherm have been con¢rmed by
repeated experiments. The size of uncoated polystyrene par-
ticles as measured by photon correlation spectroscopy was
1173.2T 12.4 nm. The average increase in the hydrodynamic
radius for a BSA-coated polystyrene particle is 4.0^4.5 nm
and is irrespective of samples taken at various points along
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the adsorption isotherm (100, 250 and 600 Wg/ml) (Table 1).
Therefore, the position on the isotherm has little e¡ect on the
observed Stokes radius. By considering the approximate ellip-
soid dimensions of BSA (3.8U3.8U14.0 nm) [1,5] these ob-
servations correlate closely with the side-on mode of BSA
adsorption at all points along the isotherm. These observa-
tions are in accordance with previous experiments using sub-
micrometre polystyrene particles [1,5].
Protein-coated polystyrene particles, taken at BSA equilib-
rium concentrations of 250 and 600 Wg/ml, were subjected to
PEGylation with cyanuric chloride-activated mPEG-5000.
The incubation containing 250 mg BSA/ml generates polysty-
rene particles with 3.05U104 surface-bound BSA molecules
(occupying 48.5% of the total surface area) (PS250), whereas
incubation at an equilibrium concentration of 600 Wg BSA/ml
generates particles bearing 5.57U104 surface-adsorbed BSA
molecules (occupying 89.9% of the total surface area)
(PS600). Following the PEGylation step we have calculated
an average of 7.3 T 0.2 and 4.1T 0.3 Wmol PEG/Wmol protein
for polystyrene particles coated with 3.05U104 and 5.57U104
BSA molecules, respectively.
We have also assessed surface hydrophilicity and popula-
tion heterogeneity of BSA-coated as well as the two PEGy-
lated particulate preparations by hydrophobic interaction
chromatography. Both types of BSA-coated particles ad-
sorbed strongly to the column at high salt concentrations;
approximately 3 and 12% of PS250 and PS600 particles were
eluted under 1.0 M salt concentration (Fig. 2). The bulk of
BSA-coated particles were eluted at a low salt concentration
(0.25 M NaCl and 0.05% w/v Triton X-100), thus demonstrat-
ing their relative hydrophobic nature. Passing a suspension of
PEGylated PS250 particles in 1.0 M sodium chloride through a
hydrophobic column retained the majority of particles; only
20% of the total particles were eluted (F1a fraction) (Fig. 3a).
When the sodium chloride concentration was reduced to 0.5 M
with a concomitant increase in Triton X-100 concentration,
multiple peaks were observed spectrophotometrically on elu-
tion from the column. The peaks collected under F2a and F3a
fractions correspond to 33% and 43% of the total amount of
particles placed on the column. The electrophoretic mobility
of the three collected fractions was considerably lower than
the BSA-coated particles under identical conditions (Table 2).
This is due to the steric protection by the surface mPEG
molecules. Among the three fractions, the electrophoretic mo-
bility of F1a particles was considerably less negative than
those of F2a and F3a. These results clearly indicate surface
heterogeneity, with three distinct populations, among the PE-
Gylated PS250 particles under these experimental conditions.
Interestingly, according to particle size analysis PEGylation
had no signi¢cant e¡ect on increasing the hydrodynamic layer
thickness of F2a and F3a particles when compared to PS250
particles (Table 2). Since the electrophoretic mobility of these
two populations is considerably di¡erent from PS250 particles
(Table 2), conjugated mPEG chains themselves could be ad-
sorbed to the particle surface, therefore exhibiting a predom-
inantly non-overlapped or weakly overlapped mushroom con-
¢guration [8]. On the other hand, the considerable increase in
the hydrodynamic radius of F1a particles (V4 nm) suggests
that the attached mPEG-5000 molecules are projected from
the surface in mushroom^brush and/or brush con¢gurations
[8,9]. Further PEGylation of the three fractions had no sig-
ni¢cant e¡ect on hydrodynamic layer thickness and the elec-
trophoretic mobility of the particles (data not shown) thus
suggesting complete surface PEGylation during the ¢rst step.
In contrast to PEGylated PS250 particles, the passage of
PEGylated PS600 particles in 1.0 M sodium chloride through
the hydrophobic column failed to retain the majority of the
particles (F1b fraction) (Fig. 3b). The remaining particles
(20% of the total) were eluted (F2b) following reduction in
sodium chloride concentration. Again, the electrophoretic mo-
bility measurements (Table 2) con¢rmed that particles col-
lected in the F1b fraction have the least negative value and
hence are more hydrophilic when compared to those eluted
under the F2b fraction. Again, the signi¢cant increase in hy-
Fig. 1. Adsorption isotherm for BSA at pH 7.4, I=0.15, T=24‡C.
Table 1
The size of uncoated polystyrene particles and those coated with







thickness of BSA (nm)
0.0 1173.2T 12.4 0.0
100.0 1181.3T 9.4 4.1
250.0 1182.9T 7.5 4.8
600.0 1182.1T 9.3 4.5
Polydispersity index was less than 0.07 for all measurements.
Fig. 2. Hydrophobic interaction chromatography of BSA-coated
polystyrene microspheres on a column of pentyl-agarose. The ¢nal
equilibrium concentration of BSA was either 250 Wg/ml (BSA 250-
coated) or 600 Wg/ml (BSA 600-coated). The elution gradient is also
shown (solid lines), the two numbers above each gradient step rep-
resent the molarity of sodium chloride (left) and %v/v of Triton
X-100. The above pro¢le was reproducible and tested with three dif-
ferent preparations of BSA-coated particles.
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drodynamic radii (approximately 4^6 nm) of both F1b and
F2b particles in comparison to PS600 particles (Table 2)
closely correlates with surface-projected mPEG molecules in
a predominantly mushroom^brush/brush con¢guration [9].
3.2. Particle phagocytosis
The kinetics of association of uncoated polystyrene particles
with J774 A1 murine macrophage-like cells was characterised
by a rapid initial increase at 37‡C followed by a gradual
decline reaching saturation level at 6 h (data not shown).
Incubation of cells with polystyrene particles at 4‡C, which
only allows for surface adsorption, demonstrated that 85% of
the total particles are internalised by the macrophage-like cells
after 6 h incubation at 37‡C. The phagocytic uptake of pro-
tein-coated and PEGylated particles was also compared to
that of uncoated polystyrene particles (Fig. 4). The uptake
of BSA-coated particles was similar to those of uncoated en-
tities regardless of the amount of surface-adsorbed BSA.
Among the three fractions of PEGylated PS250 particles the
F1a fraction was most resistant to phagocytosis, whereas the
uptake of both F2a and F3a particles was reduced by only
20% when compared to control incubations containing un-
coated particles (Fig. 4a). Further treatment of F2a and F3a
PEGylated particles with poloxamine 908 signi¢cantly sup-
pressed phagocytosis (approximately by 80% as compared to
incubations with uncoated particles). In contrast to these, the
macrophage uptake of poloxamine-treated F1a particles was
reduced by a further 10% in comparison to non-treated F1a
particles.
Similar to F1a particles, the two fractions of PEGylated
PS600 particles (F1b and F2b) were also poorly recognised
by macrophages and among them F1b particles were most
resistant to phagocytosis (approximately 30% of uncoated
control) (Fig. 4b). The results in Fig. 4c demonstrate a re-
markable linear relationship between the zeta potential of
particles in bu¡er and the extent of phagocytosis by the mac-
rophage-like cells. Thus, the extent of phagocytosis can be
predicted by measuring the zeta potential of the particles.
Cells exposed to all types of particles appeared to be morpho-
logically intact, and when assayed for viability using trypan
blue, greater than 95% of cells excluded the dye.
3.3. Complement activation
Complement haemolytic assays were used to detect activa-
tion of the human complement system by surface-engineered
particles. Human serum was incubated with particles for 1 h
at 37‡C and the residual complement haemolytic activity was
quanti¢ed. A reduction in the residual complement haemo-
lytic activity of serum signi¢es activation of the complement
system by particles. The detection of this reduction is sensitive
to the initial levels of complement present in serum. The re-
sults in Fig. 5 show that the residual complement haemolytic
activities of human serum exposed to uncoated and BSA-
coated particles are similar; following exposure 40% of resid-
ual complement activity remained. This indicated the comple-
ment-activating nature of both uncoated and BSA-coated par-
ticles. However, PEGylated particle fractions were poor
activators of the complement system with the majority of
Fig. 3. Hydrophobic interaction chromatography of mPEG-5000-grafted BSA-coated polystyrene microspheres on a column of pentyl-agarose.
In panel a microspheres were coated with BSA at a ¢nal equilibrium concentration of 250 Wg/ml prior to PEGylation and in panel b micro-
spheres were coated with BSA at a ¢nal equilibrium concentration of 600 Wg/ml prior to PEGylation. The elution gradient is also shown (dot-
ted line), the two numbers above each gradient step represent the molarity of sodium chloride (left panel) and %v/v of Triton X-100 (right pan-
el). The above pro¢le was reproducible and tested with three di¡erent preparations of PEGylated BSA-coated particles. Designated fractions
were pooled, concentrated and washed for further biophysical analysis.
Table 2
Physical characteristics of BSA-coated and mPEG-grafted microspheres following hydrophobic interaction chromatography
Microsphere type Hydrodynamic diameter (nm) Electrophoretic mobility (1038 m2/Vs) Zeta potential (mV)
PS250 1183.2T 7.5 36.01T 0.15 376.7T 1.8
PS250 (F1a) 1190.3T 3.4 32.76T 0.06 335.3T 0.3
PS250 (F2a) 1184.6T 6.2 34.16T 0.03 347.8T 1.3
PS250 (F3a) 1184.3T 8.4 34.68T 0.28 359.7T 3.6
PS600 1181.1T 4.6 36.39T 0.11 381.5T 1.4
PS600 (F1b) 1192.1T 5.7 32.34T 0.10 329.8T 1.3
PS600 (F2b) 1189.7T 3.4 32.97T 0.06 337.8T 0.4
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the residual complement activity remaining following expo-
sure of the most hydrophilic particles (F1a and F1b fractions),
or particles with predominant mushroom^brush/brush mPEG
con¢guration. It is of note that even the most hydrophilic
particles (F1b fraction) could still activate the complement
system. Crossed immunoelectrophoresis of complement com-
ponent C3 also con¢rmed C3 cleavage with all tested systems
(data not shown).
4. Discussion
The PEGylation reaction demonstrated covalent attach-
ment of more activated mPEG-5000 molecules, on an average
basis, per surface-bound BSA molecule for PS250 rather than
PS600 particles. These observations may be due to di¡erences
in the mode of BSA adsorption which vary at di¡erent pla-
teau levels of the adsorption isotherm. Previous studies have
Fig. 4. Microsphere uptake by J774 A1 cells. Uptake of uncoated particles is considered 100%. The results of test microspheres are expressed
as % uptake of uncoated particles. In panel a microspheres were coated with BSA at a ¢nal equilibrium concentration of 250 Wg/ml and in
panel b microspheres were coated with BSA at a ¢nal equilibrium concentration of 600 Wg/ml. Microspheres F1a, F2a, F3a, F1b and F2b are
PEGylated and represent pooled fractions from the hydrophobic interaction chromatography experiment (see Fig. 3). In panel c the relationship
between microsphere zeta potential and phagocytic uptake is presented.
Fig. 5. E¡ect of mPEG-5000 on human complement activation by surface-engineered microspheres. In panel a microspheres were coated with
BSA at a ¢nal equilibrium concentration of 250 Wg/ml and in panel b microspheres were coated with BSA at a ¢nal equilibrium concentration
of 600 Wg/ml. Microspheres F1a, F2a, F3a, F1b and F2b are PEGylated and represent pooled fractions from the hydrophobic interaction chro-
matography experiment (see Fig. 3).
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established that the surface-adsorbed BSA is in a form close
to its native conformation, in both the lower and ¢nal plateau
regions of the adsorption isotherm [5]. At low equilibrium
concentrations (e.g. 250 Wg/ml), BSA adsorption to the par-
ticles proceeds by a random uncorrelated irreversible mode,
which may or may not involve conformational change [5].
However, at the ¢nal plateau a transition to a co-operative
mode is believed to occur in which a close-packed protein
monolayer is formed [5]. Therefore, close proximity of BSA
molecules in a close-packed monolayer, as in PS600 particles,
may generate geometric factors and surface dynamics (e.g.
steric factors), which are less favourable for coupling to
more activated mPEG-5000 molecules when compared to
PS250 particles.
PEGylation of both types of BSA-coated polystyrene par-
ticles generated a heterogeneous population of entities that
di¡ered in surface characteristics and in vitro biological per-
formance. It seems that the mode of BSA adsorption to the
polystyrene surface as well as the extent of proximity of ad-
sorbed protein molecules to each other can control the extent
of surface heterogeneity of particles following PEGylation.
Even higher starting concentrations of activated mPEGs (up
to 200-fold molar excess to the adsorbed albumin) failed to
reduce or totally abandon the heterogeneity phenomenon [1].
Hydrophobic interaction chromatography data suggested that
the majority of particles bear a relatively homogeneous hydro-
philic surface (F1b fraction) when a close-packed BSA mono-
layer is PEGylated. The close proximity of adsorbed BSA
molecules appears to generate an e¡ective ‘molecular PEG
cloud’ to resist phagocytosis. The thickness of the ‘molecular
PEG cloud’ is approximately 4 nm. This implies that the
grafted mPEG molecules are predominantly in a brush-like
con¢guration [9]. Regardless of surface topology both particle
recognition by macrophages and complement activation are
not totally inhibited. This indicates that a fraction of the
particles (which cannot be separated by hydrophobic interac-
tion chromatography) have surface defects, which allows com-
plement activation and phagocytosis to occur, albeit at much
lower levels when compared to uncoated particles of identical
size distribution. Conversely, surface homogeneity of PEGy-
lated particles decreases substantially when BSA is adsorbed
below the upper plateau region (e.g. when 50% of the total
surface area is covered by BSA). Here, three di¡erent popu-
lations of PEGylated particles (F1a, F2a and F3a) were clas-
si¢ed by hydrophobic interaction chromatography. Among
them, the F1a particles exhibited biological performance (re-
sistance to phagocytosis and poor complement activating abil-
ity) similar to that of the F1b and F2b fractions of PEGylated
PS600 particles. Therefore, we can speculate that these three
particle populations di¡er in surface PEG density as well as
conformation. For instance, the F1a-type particles may ex-
press random regions of high PEG density in mushroom^
brush and/or brush-like conformation (arising from closely
associated PEGylated albumin molecules) separated by poor
or non-PEG-enriched (naked) areas. In contrast, frequency of
expression of high PEG density regions on F2a and F3a par-
ticles must be considerably lower than that of the F1a frac-
tion. These particles are likely to have large surface areas,
which are either naked and/or shielded by isolated rather
than closely associated mPEG^BSA conjugates with PEG
chains adsorbed onto the particle surface (a mushroom con-
¢guration). These speculations are supported by the higher
electrophoretic mobility values of F2a and F3a particles com-
pared to F1a particles as well as di¡erences in the hydrody-
namic mPEG layer thickness. Since surface PEGylation of all
three populations is complete, the mode and the proximity of
the adsorbed proteins seem to control the con¢guration of
surface-attached mPEG molecules. Experiments with polox-
amine 908 further support the above hypothesis, as polox-
amine is able to mask naked (BSA-coated) surface patches
on the F2a and F3a particles resulting in poor particle recog-
nition by macrophages [10]. Indeed, poloxamine can adsorb
e⁄ciently onto the surface of protein-coated polystyrene par-
ticles [10,11]. According to suggestions of McPherson et al. [8]
surface-adsorbed mPEG molecules, as in the case of F2a and
F3a particles, are expected to block the adsorption sites for
proteins but the results show potent complement activation by
such surfaces. Therefore, for e¡ective suppression of comple-
ment activation mPEG molecules must be in a predominant
brush-like con¢guration as this can sterically suppress depo-
sition of large C3 convertases (for instance dimensions of the
convertase C3bBb are about 14U8 nm) [12]. We strongly
emphasize that the generation of all designated populations
of PEGylated PS250 and PS600 particles was reproducible; this
may be indicative of some spontaneously controlled self-as-
sembly surface phenomenon. This heterogeneity is not speci¢c
to BSA-coated polystyrene particles. Previously, we demon-
strated that PEGylation of IgG-coated polystyrene particles
also produces a heterogeneous population of entities with re-
spect to surface characteristics [1].
The electrophoretic mobility measurements (or zeta poten-
tial) are routinely used for characterisation of sterically stabi-
lised particles [13^16]. Interestingly, the results of the current
study demonstrated a linear relationship between the zeta po-
tential and the extent of particle uptake by macrophages. The
failure of previous studies in establishing a direct correlation
between surface properties of long-circulating particles and
phagocytosis appears to be due to population heterogeneity
and the proportion of each population within the mixture [13^
16].
The results of this work may also be relevant to poorly
understood biological behaviour of PEGylated liposomes.
For example, Doxil0, a PEGylated liposomal formulation
containing doxorubicin, has a biphasic circulation half-life
of 84 min and 46 h in humans, respectively [17]. In addition
to this, Doxil0 is a potent activator of the human complement
system with activation taking place within minutes [18].
Doxil0 contains 5^7 mol% mPEG^phospholipid with sur-
face-projected mPEG chains in a mushroom^brush con¢gura-
tion, which explain the prolonged circulation times of the
vesicles. However, the macrophage clearance of a small frac-
tion of Doxil0 within 1^2 h post injection and its complement
activating nature may arise from vesicle heterogeneity in a
scenario similar to population heterogeneity of PEGylated
BSA-coated particles. Our preliminary hydrophobic interac-
tion chromatography studies with PEGylated liposomes,
with identical lipid composition to Doxil0, have indicated
considerable surface heterogeneity with some populations
poorly protected by mPEG chains (unpublished data). In
summary, our data strongly suggest that surface PEGylation
of particles spontaneously generates a heterogeneous popula-
tion of entities with di¡erent biological performance. Hydro-
phobic interaction chromatography can readily assess the ex-
tent of surface heterogeneity of PEGylated particulate drug
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delivery systems and identify particles with optimal biological
behaviour (e.g. resistant to phagocytosis, minimising comple-
ment activation and possibility of complement-mediated pseu-
doallergic responses). For optimal macrophage-resistant prop-
erty, a homogeneous mPEG-grafted surface in a predominant
mushroom^brush/brush con¢guration is essential. Our obser-
vations may also be relevant with respect to successful surface
camou£aging of depot and implantable devices.
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